1.08
+11.34%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Spectral Medical
Its shares trade on Toronto Stock Exchange under the ticker EDT.TO. It has been listed since 16 July 1992. In the fiscal year to 31 December 2025, it reported revenue of C$2.4m and a net loss of C$47.7m. At that date it held total assets of C$6.1m and shareholders' equity of −C$69.7m.
Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario. The firm has developed a product for the treatment of patients with septic shock, Toraymyxin (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s Endotoxin Activity Assay (EAA). The EAA is a rapid in-vitro diagnostic test that measures negative bacterial cell wall (endotoxin) activity in a whole blood sample. The Company, through its wholly owned subsidiary, Dialco Medical Inc. (Dialco), is also commercializing a new platform, SAMI. Its platform is targeting the renal replacement therapy (RRT) market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 16 Jul 1992
- Employees
- 25
- Website
- spectraldx.com ↗
Leadership
Pay as last reported
- Dr. Paul WalkerChairman of the Board, President, since 2001C$113,875
- Mr. Chris SetoChief Executive Officer, Chief Financial Officer, Director, since 2019C$1.1m
- Mrs. Medha GuptaVice President - Finance
- Mr. John KellumChief Medical OfficerC$815,179
- Mr. Cristiano FranziDirectorC$78,016
- Ms. Janelle D'AlviseIndependent DirectorC$114,988
- Dr. David FeigalIndependent DirectorC$108,258
- Mr. Jun HayakawaIndependent Director
- Mr. William StevensIndependent DirectorC$108,250
- Mr. Ali MahdaviInvestor Relations, since 2019
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Strong Research and Development capabilities: Spectral Medical Inc has established a robust research and development department, enabling them to innovate and develop advanced medical technologies.
- Patented products: The company owns multiple patented technologies, providing a competitive advantage and protecting their intellectual property.
- Strategic partnerships: Spectral Medical Inc has formed strategic partnerships with leading healthcare organizations, enhancing their market presence and facilitating product development.
Weaknesses
- Limited market presence: Spectral Medical Inc's products are currently available in a limited number of markets, which may restrict their revenue potential.
- Dependency on key personnel: The company's success is closely tied to the expertise and contributions of key individuals, which poses a risk in terms of succession planning and talent retention.
- Regulatory hurdles: As a medical technology company, Spectral Medical Inc must navigate stringent regulatory processes, potentially leading to delays in product approvals and commercialization.
Opportunities
- Growing demand for innovative medical solutions: With an aging population and increasing healthcare needs, there is a significant opportunity for Spectral Medical Inc to tap into the rising demand for advanced medical technologies.
- Expansion into new markets: The company can explore untapped international markets, thereby diversifying their revenue streams and reducing dependency on any single market.
- Collaborations with academic institutions: Partnering with academic institutions can provide access to cutting-edge research and specialized expertise, enabling Spectral Medical Inc to further enhance their products and offerings.
Threats
- Intense competition: Spectral Medical Inc operates in a highly competitive industry, facing competition from established medical technology companies as well as emerging startups.
- Economic volatility: Any economic downturn or instability can potentially impact the purchasing power of healthcare providers and lead to a decline in demand for medical technologies.
- Stringent regulatory environment: Compliance with complex and ever-changing regulations can pose challenges for Spectral Medical Inc, including higher costs and delays in product launches.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.